Tetraaryl cyclobutane, or CB, is being studied as an option for prostate tumours that have grown resistant to current anti-androgen drugs, notably enzalutamide. Researchers have ide
from Health – The Indian Express
http://bit.ly/2aWsJlK
via
Food Channel Shows
from Tumblr http://bit.ly/2aIHI2R
No comments:
Post a Comment